Cornbread Hemp Closes Successful Seed Round
LOS ANGELES– Cornbread Hemp, a top-selling CBD brand in the US, announced the successful closing of their seed round of fundraising and the acquisition of their processing and manufacturing partner. This move marks a significant milestone for the Kentucky-based company, which has been experiencing exponential growth since its founding in 2019.
Cornbread Hemp has projected revenue of over $20 million for 2023, thanks to the success of their CBD gummies. They have also been a significant job creator in the local economy, increasing staff from just two employees in 2019 to over thirty in 2023. The acquisition of their hemp processor now gives the company full control of their supply chain, making them one of the only CBD brands in America to become vertically integrated.
“The cornerstone of our growth is our industry-defining standards,” said Eric Zipperle, co-founder and CEO of Cornbread Hemp. “As customers become more educated on the topic, they are demanding high-quality products, not just convenience. They want USDA organic, full-spectrum CBD, and they want to know where it’s coming from.”
Cornbread Hemp’s acquisition of their processing and manufacturing partner is a step towards realizing their vision of setting the gold standard for hemp and cannabis. The company wants their customers to experience peace of mind, knowing exactly where their hemp was grown, how their CBD products were made, and that those products were made with the highest commitment to safety and quality.
More than 50,000 American households have welcomed Cornbread Hemp products into their lives as a reliable tool to help address their self-care needs or those of a loved one. The company’s premium products have gained a reputation among customers for their effectiveness and quality, making Cornbread Hemp a leading player in the CBD industry.
Latest News
California’s Legal Cannabis Market Faces Declining Sales in Q1 2023
LOS ANGELES- California's legal cannabis market continues to grapple with challenges, as indicated by the latest tax and sales numbers released by the state's Department of Tax and Fee Administration. According to the agency's report ...
Organigram Enters Partnership with Phylos Bioscience to Enhance Cannabis Genetics and Technical Capabilities
LOS ANGELES-- Organigram Holdings Inc, a licensed producer of cannabis, announced today that it has forged a comprehensive technical and commercial relationship with Phylos Bioscience Inc., a renowned U.S. cannabis genetics company based in Portland, ...
Uncertain Future for Medical Cannabis Expansion in Texas as Legislative Session Nears Conclusion
AUSTIN-- As the Texas legislative session draws to a close this Memorial Day, the future of medical cannabis expansion in the state remains uncertain. Crucial legislation aimed at broadening access to low-THC medical cannabis products ...